Basic Science with Preclinical Models to Investigate and Develop Liquid Biopsy: What Are the Available Data and Is It a Fruitful Approach?
The molecular analysis of circulating analytes (circulating tumor-DNA (ctDNA), -cells (CTCs) and -RNA (ctRNA)/exosomes) deriving from solid tumors and detected in the bloodstream—referred as liquid biopsy—has emerged as one of the most promising concepts in cancer management. Compelling data have ev...
Main Authors: | Benedetta Cena, Emmanuel Melloul, Nicolas Demartines, Olivier Dormond, Ismail Labgaa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/10/5343 |
Similar Items
-
Application progress of liquid biopsy in gastric cancer
by: Xiaoting Ma, et al.
Published: (2022-09-01) -
Detection of circulating tumor-derived material in peripheral blood of pediatric sarcoma patients: A systematic review
by: Eva Kristine Ruud Kjær, et al.
Published: (2023-08-01) -
Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
by: Stéphanie Gonvers, et al.
Published: (2022-08-01) -
Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes
by: Mohammed Nimir, et al.
Published: (2019-07-01) -
Editorial: The impact of liquid biopsies in the management of liver cancer
by: Ismail Labgaa
Published: (2022-11-01)